ALK and neoplasm: Our results show that TrkA sustains the survival of NPM‐ALK+ T‐cell lymphoma through association and interactions with NPM‐ALK, and suggest that inhibition of TrkA signaling could be utilized as a potential strategy to combat this aggressive neoplasm.